Parkinson’s News Today (2/22, Maia) reports, “Among several atypical antipsychotics, Nuplazid (pimavanserin) seems to be the most effective at easing Parkinson’s disease psychosis…while sparing motor function,” researchers concluded in the findings of a 19-study systematic review and network meta-analysis that “evaluated outcomes with Nuplazid and other atypical antipsychotics such as clozapine, quetiapine, olanzapine, ziprasidone, and risperidone.” The findings were published online in the Journal of Geriatric Psychiatry & Neurology.
Related Links:
— “Nuplazid, clozapine treat Parkinson’s psychosis without motor decline “Margarida Maia, Parkinson’s News Today, February 22, 2023